Total Knee Replacement With Duracon® and Vanguard™ Prostheses
Information source: Biomet, Inc.
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Degenerative Arthritis; Osteoarthritis; Rheumatoid Arthritis; Knee Arthritis
Intervention: Duracon® (Device); Vanguard™ (Device)
Phase: N/A
Status: Active, not recruiting
Sponsored by: Biomet Orthopedics, Inc.
Summary
The purpose of this study is to compare range of motion, Knee Society Scores, and duration of
surgery for different total knee prostheses.
Clinical Details
Study design: Cohort, Prospective
Primary outcome: Range of motion, Knee Society Score, Duration of surgery
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patients with painful and disabled knee joint resulting from osteoarthritis,
rheumatoid arthritis, traumatic arthritis where one or more compartments are
involved.
- Patients requiring correction of varus, valgus, or posttraumatic deformity.
- Patients requiring correction or revision of unsuccessful osteotomy, arthrodesis, or
failure of previous joint replacement procedure.
Exclusion Criteria:
- Patients with infection, sepsis, or osteomyelitis.
Locations and Contacts
Biomet Orthopedics, Inc., Warsaw, Indiana 46581, United States
Additional Information
Starting date: June 2005
Ending date: June 2008
Last updated: January 3, 2008
|
